INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹95 Cr | ₹155 Cr | ₹179 Cr | ₹174 Cr | ₹82 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹95 Cr |
| Mar2024 | ₹155 Cr |
| Mar2023 | ₹179 Cr |
| Mar2022 | ₹174 Cr |
| Mar2021 | ₹82 Cr |
How is Cash Flow from Operating Activities of INDOCO REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹95 Cr | -38.91 | |
| Mar2024 | ₹155 Cr | -13.11 | |
| Mar2023 | ₹179 Cr | 2.88 | |
| Mar2022 | ₹174 Cr | 111.41 | |
| Mar2021 | ₹82 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,016.9 Cr | -4% | -7.9% | -34.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -4% |
-7.9% |
-34.2% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses